Showing 2 posts of 2 posts found.


Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018
Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …


Biotech’s stock goes down in flames after cannabidiol drug failure

August 8, 2017
Manufacturing and Production, Research and Development GW Pharma, Zynerba, biotech, cannabidoil, drugs, pharma, pharmaceutical

Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing …

Latest content